These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23183870)

  • 1. Antibody boosting and longevity following tetanus immunization during pregnancy.
    Fowkes FJ; McGready R; Johnstone-Robertson S; Nosten F; Beeson JG
    Clin Infect Dis; 2013 Mar; 56(5):749-50. PubMed ID: 23183870
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomes as immunological adjuvants for tetanus vaccine.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):263-9. PubMed ID: 11845438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunity against tetanus 3 years after revaccination].
    Bozović M; Pavlović V
    Med Pregl; 1991; 44(1-2):77-8. PubMed ID: 1870472
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of anti-tetanus antibodies in Turkish population.
    Soyletir G; Yağci A; Topkaya A; Ciragil P
    Trop Doct; 1999 Jul; 29(3):161-3. PubMed ID: 10448241
    [No Abstract]   [Full Text] [Related]  

  • 5. Negatively charged liposomes as immunological adjuvant for tetanus and diphtheria toxoids.
    Popescu C; Durbaca S; Ivanov D
    Roum Arch Microbiol Immunol; 1998; 57(3-4):255-61. PubMed ID: 11845437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The status of maternally acquired tetanus immunity in newborn infants].
    Pietsch M; Schütt KH
    Gesundheitswesen; 1993 Jul; 55(7):364-6. PubMed ID: 8369604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetanus immunity in elderly people.
    Murphy SM; Hegarty DM; Feighery CS; Walsh JB; Williams Y; Coakley DP
    Age Ageing; 1995 Mar; 24(2):99-102. PubMed ID: 7793344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparative evaluation of the immunological efficacy of ADPT vaccine and ADT-M anatoxin in the immunization of children against diphtheria and tetanus].
    Rusakova EV; Bezuglova MS; Vasil'eva VI; Frank KD; Panina GM
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):52-5. PubMed ID: 1950266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetanus immunization status among women of childbearing age in Turkey.
    Esen B; Kurtoglu D; Coplu N; Gozalan A; Miyamura K; Ishida S; Akin L
    Jpn J Infect Dis; 2007 May; 60(2-3):92-6. PubMed ID: 17515639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tetanus antitoxin levels and reactions following tetanus vaccination].
    Kuhlwein A; Bleyl A
    Hautarzt; 1985 Aug; 36(8):462-4. PubMed ID: 3899998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses of Asian elephants (Elephas maximus) to commercial tetanus toxoid vaccine.
    Lindsay WA; Wiedner E; Isaza R; Townsend HG; Boleslawski M; Lunn DP
    Vet Immunol Immunopathol; 2010 Feb; 133(2-4):287-9. PubMed ID: 19720403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-tetanus immunity and vaccination by the lingual route].
    Ruiz Merino J
    Rev Sanid Hig Publica (Madr); 1982; 56(5-6):469-77. PubMed ID: 6764298
    [No Abstract]   [Full Text] [Related]  

  • 13. [Generalized tetanus in a teenager].
    Valla FV; Gay CL
    Arch Pediatr; 2007 Apr; 14(4):362-4. PubMed ID: 17267185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetanus IgG antibody levels in children aged 12 to 47 months in Turkey.
    Yildirim RC; Yilmaz N; Yildirim U; Aksakal FN
    Am J Infect Control; 2001 Apr; 29(2):120-3. PubMed ID: 11287881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to tetanus of a rural population in a Greek county.
    Mendrinou E; Kouzelis A; Georgakopoulos P; Dodou V; Regli A
    New Microbiol; 2004 Apr; 27(2):187-9. PubMed ID: 15164631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of diphtheria and tetanus vaccination in Gaza, Palestine.
    Al Aswad IH; Shubair ME
    East Mediterr Health J; 2009; 15(2):285-94. PubMed ID: 19554974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological effectiveness of secondary revaccination against tetanus performed at prolonged intervals].
    Maksimova NM; Basova NN; Sukhorukova NL; Finkel' MP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):43-6. PubMed ID: 3307239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control of tetanus from the immunobiological point of view].
    Zimmermann G
    Z Arztl Fortbild (Jena); 1975 Dec; 69(24):1284-6. PubMed ID: 766430
    [No Abstract]   [Full Text] [Related]  

  • 19. Tetanus immunity among intravenous drug users in Guipuzcoa (Basque Country, Spain).
    Cilla G; Pérez-Trallero E; Sáenz-Dominguez JR; Esparza H; Otero F
    AIDS; 1994 Feb; 8(2):271-2. PubMed ID: 8043235
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tetanus: antibody levels and vaccination history in a target group of the Latium population].
    Mastroeni I; Tarsitani G; Vescia N; Cantalamessa Carboni L; D'Arca T; De Stefanis B; Feola P; Raponi A
    Nuovi Ann Ig Microbiol; 1988; 39(2):149-60. PubMed ID: 3072525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.